Teratogenic effect of carbamazepine.
Open Access
- 1 May 1991
- journal article
- case report
- Published by BMJ in Archives of Disease in Childhood
- Vol. 66 (5) , 641-642
- https://doi.org/10.1136/adc.66.5.641
Abstract
A girl was born to a mother who had undergone treatment for epilepsy with carbamazepine during pregnancy. The infant had dysmorphic features and was physically and mentally retarded. We consider that the malformations were the result of the maternal treatment with carbamazepine.Keywords
This publication has 6 references indexed in Scilit:
- Pattern of Malformations in the Children of Women Treated with Carbamazepine during PregnancyNew England Journal of Medicine, 1989
- Teratogenicity of Antiepileptic Drugs: Analysis of Possible Risk FactorsEpilepsia, 1988
- Anticonvulsant drugs in monotherapy. Effect on the fetusEuropean Journal of Epidemiology, 1987
- Maternal epilepsy and birth defects: A case-control study in the Italian Multicentric Registry of Birth Defects (IPIMC)European Journal of Epidemiology, 1985
- Carbamazepine and carbamazepine-10,11- epoxide during pregnancy and postnatal period in epileptic mother and their nursed infants: pharmacokinetics and clinical effects.1983
- FETAL HEAD GROWTH RETARDATION ASSOCIATED WITH MATERNAL ANTIEPILEPTIC DRUGSThe Lancet, 1981